SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-157358
Filing Date
2017-05-04
Accepted
2017-05-04 08:00:56
Documents
4
Period of Report
2017-05-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d381606d8k.htm 8-K 22811
2 EX-10.1 d381606dex101.htm EX-10.1 63324
3 EX-99.1 d381606dex991.htm EX-99.1 9063
4 GRAPHIC g381606g28s12.gif GRAPHIC 4889
  Complete submission text file 0001193125-17-157358.txt   103313
Mailing Address AESCHENVORSTADT 36 BASEL V8 4051
Business Address AESCHENVORSTADT 36 BASEL V8 4051 6173154600
CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37923 | Film No.: 17811951
SIC: 2836 Biological Products, (No Diagnostic Substances)